Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00302900 · ClinicalTrials.gov registry record · Phase 2
Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations
A Phase 2 study, sponsored by Ohio University.
- Completed
- Registry status
- Phase 2
- Development phase
- 441
- Enrollment target
NCT00302900 is a Phase 2 study that has completed, run by Ohio University. The registered enrollment target is 441 participants.
The verdict
NCT00302900, a Phase 2 study, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 441 participants
- Enrollment target
Study Summary
Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative reactions among new blood donors. This study will also evaluate whether reducing negative reactions increases the likelihood of donors returning to give blood in the future.
Interventions
- BEHAVIORAL Pre-Donation Water Consumption
- BEHAVIORAL Muscle Tensing Exercise During Donation
- BEHAVIORAL Muscle Tensing Exercise Prior to Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00302900
The ClinicalTrials.gov registry entry for NCT00302900 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 441 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pre-Donation Water Consumption is the first listed.
NCT00302900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00302900 about?
NCT00302900 is a clinical study titled "Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations". Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to...
What is the current status of trial NCT00302900?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 441 participants. The study started on 2006-01. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00302900?
The interventions under investigation include: Pre-Donation Water Consumption (BEHAVIORAL), Muscle Tensing Exercise During Donation (BEHAVIORAL), Muscle Tensing Exercise Prior to Donation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00302900?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.